PDB Short entry for 5FP5 HEADER TRANSFERASE 27-NOV-15 5FP5 TITLE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH SMALL-MOLECULE LIGAND 4- TITLE 2 FLUOROBENZOIC ACID (AT222) IN AN ALTERNATE BINDING SITE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CELL DIVISION PROTEIN KINASE 2, P33 PROTEIN KINASE; COMPND 5 EC: 2.7.11.22; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS TRANSFERASE, KINASE, MITOSIS, CELL CYCLE, FRAGMENT SCREENING, KEYWDS 2 ALTERNATE BINDING SITE. EXPDTA X-RAY DIFFRACTION AUTHOR H.JHOTI,R.F.LUDLOW,M.O'REILLY,H.K.SAINI,I.J.TICKLE,M.VERDONK REVDAT 6 10-JAN-24 5FP5 1 REMARK REVDAT 5 28-APR-21 5FP5 1 REMARK REVDAT 4 28-AUG-19 5FP5 1 JRNL REMARK LINK ATOM REVDAT 3 13-JAN-16 5FP5 1 JRNL REMARK REVDAT 2 23-DEC-15 5FP5 1 JRNL REVDAT 1 09-DEC-15 5FP5 0 JRNL AUTH R.F.LUDLOW,M.L.VERDONK,H.K.SAINI,I.J.TICKLE,H.JHOTI JRNL TITL DETECTION OF SECONDARY BINDING SITES IN PROTEINS USING JRNL TITL 2 FRAGMENT SCREENING. JRNL REF PROC.NATL.ACAD.SCI.USA V. 112 15910 2015 JRNL REFN ISSN 0027-8424 JRNL PMID 26655740 JRNL DOI 10.1073/PNAS.1518946112 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH P.G.WYATT,A.J.WOODHEAD,V.BERDINI,J.A.BOULSTRIDGE,M.G.CARR, REMARK 1 AUTH 2 D.M.CROSS,D.J.DAVIS,L.A.DEVINE,T.R.EARLY,R.E.FELTELL, REMARK 1 AUTH 3 E.J.LEWIS,R.L.MCMENAMIN,E.F.NAVARRO,M.A.O'BRIEN,M.O'REILLY, REMARK 1 AUTH 4 M.REULE,G.SAXTY,L.C.A.SEAVERS,D.SMITH,M.S.SQUIRES, REMARK 1 AUTH 5 G.TREWARTHA,M.T.WALKER,A.J.WOOLFORD REMARK 1 TITL IDENTIFICATION OF REMARK 1 TITL 2 N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO) REMARK 1 TITL 3 -1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN REMARK 1 TITL 4 DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY REMARK 1 TITL 5 CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. REMARK 1 REF J.MED.CHEM. V. 51 4986 2008 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 18656911 REMARK 1 DOI 10.1021/JM800382H REMARK 2 REMARK 2 RESOLUTION. 2.16 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.16 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.01 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.1 REMARK 3 NUMBER OF REFLECTIONS : 14466 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 731 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 7 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.16 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.33 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 88.89 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2798 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2011 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2660 REMARK 3 BIN R VALUE (WORKING SET) : 0.1966 REMARK 3 BIN FREE R VALUE : 0.2883 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.93 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 138 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2076 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 23 REMARK 3 SOLVENT ATOMS : 321 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.09 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.84040 REMARK 3 B22 (A**2) : 2.65260 REMARK 3 B33 (A**2) : -0.81210 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.242 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.392 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.244 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.294 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.229 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.907 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2160 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2934 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 708 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 40 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 328 ; 16.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2160 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 273 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2776 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.04 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 5.87 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.01 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: NULL REMARK 3 ORIGIN FOR THE GROUP (A): 20.1137 1.4260 66.3227 REMARK 3 T TENSOR REMARK 3 T11: -0.0667 T22: 0.0407 REMARK 3 T33: 0.0060 T12: -0.0111 REMARK 3 T13: 0.0135 T23: 0.0927 REMARK 3 L TENSOR REMARK 3 L11: 1.1178 L22: 0.0748 REMARK 3 L33: 0.4592 L12: -1.1947 REMARK 3 L13: -0.4848 L23: 0.6036 REMARK 3 S TENSOR REMARK 3 S11: -0.0073 S12: 0.0007 S13: -0.0082 REMARK 3 S21: -0.0506 S22: 0.0338 S23: 0.0699 REMARK 3 S31: 0.0131 S32: -0.0561 S33: -0.0265 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: NULL REMARK 3 ORIGIN FOR THE GROUP (A): 31.6335 2.1913 58.0783 REMARK 3 T TENSOR REMARK 3 T11: -0.0123 T22: 0.0392 REMARK 3 T33: -0.0403 T12: 0.0092 REMARK 3 T13: -0.0025 T23: 0.0764 REMARK 3 L TENSOR REMARK 3 L11: 0.3762 L22: 0.0000 REMARK 3 L33: 0.7724 L12: 0.2176 REMARK 3 L13: -1.2358 L23: 0.1674 REMARK 3 S TENSOR REMARK 3 S11: 0.0006 S12: -0.0309 S13: -0.0031 REMARK 3 S21: 0.0079 S22: -0.0138 S23: 0.0123 REMARK 3 S31: -0.0004 S32: 0.0059 S33: 0.0132 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): 33.4641 6.5356 42.2810 REMARK 3 T TENSOR REMARK 3 T11: -0.0364 T22: -0.0192 REMARK 3 T33: -0.0645 T12: 0.0078 REMARK 3 T13: 0.0020 T23: -0.0013 REMARK 3 L TENSOR REMARK 3 L11: 1.1992 L22: 0.7243 REMARK 3 L33: 1.3373 L12: -0.4218 REMARK 3 L13: 0.3386 L23: -0.3421 REMARK 3 S TENSOR REMARK 3 S11: 0.0050 S12: 0.0026 S13: 0.0081 REMARK 3 S21: 0.0255 S22: -0.0095 S23: 0.0056 REMARK 3 S31: -0.0080 S32: 0.0476 S33: 0.0046 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5FP5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-NOV-15. REMARK 100 THE DEPOSITION ID IS D_1290065633. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-MAY-02 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : DTSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14466 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.160 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.700 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.1 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1HCK REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10MM HEPES/NAOH PH7.4 15MM NACL REMARK 280 PROTEIN CONCENTRATION: 8.6 MG/ML REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.83850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.19100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.84900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 36.19100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.83850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.84900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 14 REMARK 465 ARG A 36 REMARK 465 LEU A 37 REMARK 465 ASP A 38 REMARK 465 THR A 39 REMARK 465 GLU A 40 REMARK 465 THR A 41 REMARK 465 GLU A 42 REMARK 465 GLY A 43 REMARK 465 VAL A 44 REMARK 465 PRO A 45 REMARK 465 SER A 46 REMARK 465 GLU A 73 REMARK 465 ASN A 74 REMARK 465 LYS A 75 REMARK 465 ALA A 149 REMARK 465 ARG A 150 REMARK 465 ALA A 151 REMARK 465 PHE A 152 REMARK 465 GLY A 153 REMARK 465 VAL A 154 REMARK 465 PRO A 155 REMARK 465 VAL A 156 REMARK 465 ARG A 157 REMARK 465 THR A 158 REMARK 465 TYR A 159 REMARK 465 THR A 160 REMARK 465 HIS A 161 REMARK 465 GLU A 162 REMARK 465 VAL A 163 REMARK 465 VAL A 164 REMARK 465 LEU A 296 REMARK 465 ARG A 297 REMARK 465 LEU A 298 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 5 CD OE1 NE2 REMARK 470 LYS A 6 CD CE NZ REMARK 470 LYS A 9 CE NZ REMARK 470 GLU A 12 CD OE1 OE2 REMARK 470 LEU A 25 CG CD1 CD2 REMARK 470 LYS A 33 NZ REMARK 470 LYS A 34 CE NZ REMARK 470 THR A 47 CG2 REMARK 470 ILE A 49 CG2 REMARK 470 ARG A 50 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 51 CG CD OE1 OE2 REMARK 470 ILE A 52 CD1 REMARK 470 LYS A 88 NZ REMARK 470 THR A 97 CG2 REMARK 470 ARG A 122 CD NE CZ NH1 NH2 REMARK 470 LEU A 148 CB CG CD1 CD2 REMARK 470 LYS A 178 CD CE NZ REMARK 470 LYS A 242 NZ REMARK 470 GLN A 246 CG CD OE1 NE2 REMARK 470 LYS A 278 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 58 96.77 -54.52 REMARK 500 ARG A 126 -21.84 80.13 REMARK 500 TYR A 179 53.43 -112.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2013 DISTANCE = 7.52 ANGSTROMS REMARK 525 HOH A2107 DISTANCE = 5.85 ANGSTROMS REMARK 525 HOH A2149 DISTANCE = 7.21 ANGSTROMS REMARK 525 HOH A2150 DISTANCE = 6.91 ANGSTROMS REMARK 525 HOH A2314 DISTANCE = 5.96 ANGSTROMS REMARK 525 HOH A2316 DISTANCE = 5.93 ANGSTROMS REMARK 525 HOH A2318 DISTANCE = 5.82 ANGSTROMS REMARK 525 HOH A2319 DISTANCE = 6.12 ANGSTROMS REMARK 525 HOH A2320 DISTANCE = 5.93 ANGSTROMS REMARK 525 HOH A2321 DISTANCE = 7.26 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 4-FLUOROBENZOIC ACID (L02): ASTEX COMPOUND REGISTRY AT222 REMARK 600 4-FLUOROBENZOIC ACID (L01): ASTEX COMPOUND REGISTRY AT222 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACE A 1296 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1Y6 A 1297 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1Y6 A 1298 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5FP6 RELATED DB: PDB REMARK 900 STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH SMALL- MOLECULE LIGAND REMARK 900 3-(4,7-DICHLORO-1H-INDOL-3-YL)PROP -2-YN-1-OL (AT17833) IN AN REMARK 900 ALTERNATE BINDING SITE. DBREF 5FP5 A 1 298 UNP P24941 CDK2_HUMAN 1 298 SEQRES 1 A 298 MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY GLU GLY SEQRES 2 A 298 THR TYR GLY VAL VAL TYR LYS ALA ARG ASN LYS LEU THR SEQRES 3 A 298 GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG LEU ASP THR SEQRES 4 A 298 GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG GLU ILE SEQRES 5 A 298 SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE VAL LYS SEQRES 6 A 298 LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU TYR LEU SEQRES 7 A 298 VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS PHE MET SEQRES 8 A 298 ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO LEU ILE SEQRES 9 A 298 LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU ALA PHE SEQRES 10 A 298 CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU LYS PRO SEQRES 11 A 298 GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE LYS LEU SEQRES 12 A 298 ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL PRO VAL SEQRES 13 A 298 ARG THR TYR THR HIS GLU VAL VAL THR LEU TRP TYR ARG SEQRES 14 A 298 ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SER THR SEQRES 15 A 298 ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE ALA GLU SEQRES 16 A 298 MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SER GLU SEQRES 17 A 298 ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU GLY THR SEQRES 18 A 298 PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER MET PRO SEQRES 19 A 298 ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG GLN ASP SEQRES 20 A 298 PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP GLY ARG SEQRES 21 A 298 SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO ASN LYS SEQRES 22 A 298 ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO PHE PHE SEQRES 23 A 298 GLN ASP VAL THR LYS PRO VAL PRO HIS LEU ARG LEU HET 1Y6 A1297 14 HET 1Y6 A1298 14 HET ACE A1296 3 HETNAM 1Y6 4-FLUOROBENZOIC ACID HETNAM ACE ACETYL GROUP FORMUL 2 1Y6 2(C7 H5 F O2) FORMUL 4 ACE C2 H4 O FORMUL 5 HOH *321(H2 O) HELIX 1 1 THR A 47 LEU A 58 1 12 HELIX 2 2 LEU A 87 SER A 94 1 8 HELIX 3 3 PRO A 100 HIS A 121 1 22 HELIX 4 4 LYS A 129 GLN A 131 5 3 HELIX 5 5 ALA A 170 LEU A 175 1 6 HELIX 6 6 THR A 182 ARG A 199 1 18 HELIX 7 7 SER A 207 GLY A 220 1 14 HELIX 8 8 GLY A 229 MET A 233 5 5 HELIX 9 9 ASP A 247 VAL A 252 1 6 HELIX 10 10 ASP A 256 LEU A 267 1 12 HELIX 11 11 SER A 276 ALA A 282 1 7 HELIX 12 12 HIS A 283 GLN A 287 5 5 SHEET 1 AA 5 PHE A 4 GLU A 12 0 SHEET 2 AA 5 VAL A 17 ASN A 23 -1 O VAL A 18 N ILE A 10 SHEET 3 AA 5 VAL A 29 LYS A 34 -1 O VAL A 30 N ALA A 21 SHEET 4 AA 5 TYR A 77 GLU A 81 -1 O LEU A 78 N LYS A 33 SHEET 5 AA 5 LEU A 66 ILE A 70 -1 N LEU A 67 O VAL A 79 SHEET 1 AB 3 GLN A 85 ASP A 86 0 SHEET 2 AB 3 LEU A 133 ILE A 135 -1 O ILE A 135 N GLN A 85 SHEET 3 AB 3 ILE A 141 LEU A 143 -1 O LYS A 142 N LEU A 134 LINK N MET A 1 C ACE A1296 1555 1555 1.34 CISPEP 1 PRO A 253 PRO A 254 0 -2.01 SITE 1 AC1 3 MET A 1 LEU A 32 TYR A 77 SITE 1 AC2 8 ALA A 31 LYS A 33 PHE A 80 GLU A 81 SITE 2 AC2 8 LEU A 83 LEU A 134 ALA A 144 ASP A 145 SITE 1 AC3 9 GLU A 138 VAL A 226 ARG A 245 HIS A 268 SITE 2 AC3 9 TYR A 269 LYS A 291 HOH A2243 HOH A2267 SITE 3 AC3 9 HOH A2268 CRYST1 53.677 71.698 72.382 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018630 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013947 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013816 0.00000